The Research Report on “Allergy Diagnostics Market by Products (Assay Kits, Immunoassay & Elisa Analyzers, Luminometers, Services), Allergens (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End Users (Hospital, Diagnostic Laboratory) – Global Forecast” published by MarketsandMarkets™, the market witnessed healthy growth during the last decade and is expected to grow at a CAGR of 10.5%, and projected to reach USD 5.74 Billion.The allergy diagnosis is an important introductory step for effective allergy treatment.
Current allergy tests are more convenient and accurate compared to the tests that were available before.
With the help of a detailed medical history, allergy tests can identify specific triggers for an individual’s allergic reactions.
This process is also required in drug development and the production process of allergy treatments.The major factors driving the growth of this market are the high incidence and large economic burden of allergic diseases, rising environmental pollution, increasing healthcare expenditure, and growing access to medical insurance in the US.
On the other hand, lack of awareness of allergic diseases in some countries is restraining the growth of this market.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=232871701Opportunity: Growing adoption of automation for quicker turnaround times;Turnaround time (TAT) is an important factor in laboratory services and is often used as a key indicator of laboratory performance.
Semi-automated instruments are also preferred as they are less expensive; however, these systems increase the TAT.
According to the new market research report “Allergy Diagnostics Market by Product & Service (Consumables, Instruments (Immunoassay Analyzer, ELISA Analyzer, Luminometer), Service), Allergen (Food, Inhaled, Drug), Test Type (In Vivo, In Vitro), End User (Diagnostic Laboratories) – Global Forecast to 2026″, published by MarketsandMarkets™, is projected to reach USD 8.2 billion by 2026 from USD 4.8 billion in 2021, at a CAGR of 11.1% from 2021 to 2026.GROWTH DRIVER: Rising environmental pollution levels;Exposure to indoor and outdoor air pollutants, allergens, and occupational exposure are the major risk factors causing chronic respiratory diseases.
The prevalence of allergic disorders among the urban population is higher than those living in rural areas due to the higher exposure to environmental pollutants in cities (as a result of vehicular pollution and industrial activities).As per the WHO, more than 80% of people living in urban areas are exposed to air quality levels that exceed the WHO safety limits; though this is a global trend, its effects are more severe in the urban areas of low-income countries.
This is a major indicator for the growth of the allergy diagnostics market, as air pollution from motor vehicles has been indicated as one of the major risk factors responsible for allergic diseases.Epidemiological and toxicological research reveals a causal relationship between air pollution and the increased incidence of asthma, allergic rhinitis, and other allergic disorders.
Studies have also demonstrated a significant increase in the incidence and exacerbation of asthma in urban locations with elevated PM 2.5 (particulate matter of size 2.5 micrometers or less), nitrogen dioxide, and ozone concentrations.Research by allergy/immunology community members has shown that pollutants augment immediate and late-phase responses to allergens.
Research also indicates that pollutants contribute to disease development, with tobacco smoke and diesel exhaust particles augmenting primary sensitization to antigens, leading to an IgE response.
Epidemiologic studies also demonstrate that exposure to ambient air pollutants contributes to increased hospitalizations, decreased lung growth, and disease development.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=232871701“Diagnostic laboratories are expected to hold the largest share of the allergy diagnostics market, by end user in 2021.”Based on end user, the market is segmented into diagnostic laboratories, hospital-based laboratories, academic research institutes, and other end users.
The Research Report on “Allergy Diagnostics Market by Products (Assay Kits, Immunoassay & Elisa Analyzers, Luminometers, Services), Allergens (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End Users (Hospital, Diagnostic Laboratory) – Global Forecast” published by MarketsandMarkets™, the market witnessed healthy growth during the last decade and is expected to grow at a CAGR of 10.5%, and projected to reach USD 5.74 Billion.The allergy diagnosis is an important introductory step for effective allergy treatment.
Current allergy tests are more convenient and accurate compared to the tests that were available before.
With the help of a detailed medical history, allergy tests can identify specific triggers for an individual’s allergic reactions.
This process is also required in drug development and the production process of allergy treatments.The major factors driving the growth of this market are the high incidence and large economic burden of allergic diseases, rising environmental pollution, increasing healthcare expenditure, and growing access to medical insurance in the US.
On the other hand, lack of awareness of allergic diseases in some countries is restraining the growth of this market.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=232871701Opportunity: Growing adoption of automation for quicker turnaround times;Turnaround time (TAT) is an important factor in laboratory services and is often used as a key indicator of laboratory performance.
Semi-automated instruments are also preferred as they are less expensive; however, these systems increase the TAT.
According to the new market research report “Allergy Diagnostics Market by Product & Service (Consumables, Instruments (Immunoassay Analyzer, ELISA Analyzer, Luminometer), Service), Allergen (Food, Inhaled, Drug), Test Type (In Vivo, In Vitro), End User (Diagnostic Laboratories) – Global Forecast to 2026″, published by MarketsandMarkets™, is projected to reach USD 8.2 billion by 2026 from USD 4.8 billion in 2021, at a CAGR of 11.1% from 2021 to 2026.GROWTH DRIVER: Rising environmental pollution levels;Exposure to indoor and outdoor air pollutants, allergens, and occupational exposure are the major risk factors causing chronic respiratory diseases.
The prevalence of allergic disorders among the urban population is higher than those living in rural areas due to the higher exposure to environmental pollutants in cities (as a result of vehicular pollution and industrial activities).As per the WHO, more than 80% of people living in urban areas are exposed to air quality levels that exceed the WHO safety limits; though this is a global trend, its effects are more severe in the urban areas of low-income countries.
This is a major indicator for the growth of the allergy diagnostics market, as air pollution from motor vehicles has been indicated as one of the major risk factors responsible for allergic diseases.Epidemiological and toxicological research reveals a causal relationship between air pollution and the increased incidence of asthma, allergic rhinitis, and other allergic disorders.
Studies have also demonstrated a significant increase in the incidence and exacerbation of asthma in urban locations with elevated PM 2.5 (particulate matter of size 2.5 micrometers or less), nitrogen dioxide, and ozone concentrations.Research by allergy/immunology community members has shown that pollutants augment immediate and late-phase responses to allergens.
Research also indicates that pollutants contribute to disease development, with tobacco smoke and diesel exhaust particles augmenting primary sensitization to antigens, leading to an IgE response.
Epidemiologic studies also demonstrate that exposure to ambient air pollutants contributes to increased hospitalizations, decreased lung growth, and disease development.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=232871701“Diagnostic laboratories are expected to hold the largest share of the allergy diagnostics market, by end user in 2021.”Based on end user, the market is segmented into diagnostic laboratories, hospital-based laboratories, academic research institutes, and other end users.